A detailed history of Generali Asset Management Spa Sgr transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Generali Asset Management Spa Sgr holds 290,157 shares of BMY stock, worth $13.2 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares
290,157
Previous 245,430 18.22%
Holding current value
$13.2 Million
Previous $15 Billion 10.27%
% of portfolio
0.31%
Previous 0.37%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 28, 2025

BUY
$44.12 - $59.6 $1.97 Million - $2.67 Million
44,727 Added 18.22%
290,157 $13.4 Billion
Q1 2025

May 15, 2025

SELL
$53.9 - $63.11 $2.08 Million - $2.43 Million
-38,531 Reduced 13.57%
245,430 $15 Billion
Q4 2024

May 29, 2025

BUY
$51.92 - $59.94 $2 Million - $2.31 Million
38,531 Added 15.7%
283,961 $16.1 Billion
Q4 2024

Feb 10, 2025

BUY
$51.92 - $59.94 $14.7 Million - $17 Million
283,961 New
283,961 $16.1 Billion

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $96.4B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Generali Asset Management Spa Sgr Portfolio

Follow Generali Asset Management Spa Sgr and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Generali Asset Management Spa Sgr, based on Form 13F filings with the SEC.

News

Stay updated on Generali Asset Management Spa Sgr with notifications on news.